Reliv International Inc (RELV) Inventory Turnover Ratio, from third quarter 2020 to third quarter 2019, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Reliv International Inc  (RELV)
 

Reliv International Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Reliv International Inc's inventory turnover ratio, the ratio that measures Reliv International Inc's ability to manage its supply chain, sequentially decreased to 3.34 in the third quarter 2020, but it does not raise any concerns as Reliv International Inc continue to execute well, and the inventory turnover ratio remains above the average. Reliv International Inc's average inventory processing period in the Sep 30 2020 quarter, has increased to 109 days, from 102 days, in the Jun 30 2020 quarter.

Within Healthcare sector 142 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1233 in the second quarter 2020, to 1236.

RELV Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Reliv International Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RELV Inventory Turnover Ratio (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Inventory Growth 20.48 % 11.77 % 24.13 % -8.57 % -47.57 %
Y / Y Cost of Sales Growth -8.32 % -2.93 % 9.09 % -10.05 % 4.78 %
Inventory Turnover Ratio (TTM) 3.34 3.57 3.7 3.81 3.82
RELV's Total Ranking # 1236 # 1233 # 1233 # 1123 # 1234
Average inventory processing period 109 102 99 96 95
Seq. Inventory Growth -6.58 % 7.77 % 4 % 15.07 % -13.34 %
Seq. Cost of Sales Growth 3.98 % -17.04 % 12.67 % -5.67 % 10.09 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 46
Healthcare Sector # 143
Overall Market # 1236

Inventory Turnover Ratio Statistics
High Average Low
3.82 2.58 1.9
(Sep 30 2019)   (Dec 31 2015)



RELV Company Profile >> Back to RELV Efficiency Comparisons >> Compare RELV Inventory Turnover Ratio to its Competitors

Financial Statements
Reliv International Inc's Inventories $ 3 Millions Visit RELV's Balance sheet
Reliv International Inc's Cost of Revenues TTM $ 10 Millions Visit RELV's Income Statement
What are RELV's Sales? Visit RELV's Sales by Segment

Other Inventory Turnover Ratios
Reliv International Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RELV's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RELV's Competitors
Inventory Turnover Ratio for RELV's Suppliers
Inventory Turnover Ratio for RELV's Customers

You may also want to know
RELV's Sales Growth Rates RELV's Pe Price to earnings ratio RELV's Receivables Turnover Ratio RELV's Stock Quote
RELV's Net Income Growth Rates RELV's Ps Price to Sales ratio RELV's Sales per Employee RELV's Asset Turnover Ratio
RELV's Net Margin RELV's Pb Price to Book ratio RELV's Financial Strength Ratios RELV's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2020, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2020 Inventories at quarter ending Sep 30 2020
Biora Therapeutics Inc   9.05 $ 72.006  Millions$ 8  Millions
Charles River Laboratories International inc   8.81 $ 1,482.624  Millions$ 168  Millions
Cryo cell International Inc   8.73 $ 9.696  Millions$ 1  Millions
Opko Health Inc   8.73 $ 647.850  Millions$ 74  Millions
Castle Biosciences Inc   8.70 $ 12.613  Millions$ 1  Millions
Incyte Corporation  8.67 $ 127.220  Millions$ 15  Millions
Biotricity Inc   8.45 $ 1.111  Millions$ 0  Millions
Steris Plc  8.31 $ 1,711.298  Millions$ 206  Millions
Surgery Partners Inc   7.95 $ 388.000  Millions$ 49  Millions
Caredx Inc   7.82 $ 61.766  Millions$ 8  Millions
Perspective Therapeutics Inc   7.70 $ 4.615  Millions$ 1  Millions
Kewaunee Scientific Corporation  7.69 $ 121.464  Millions$ 16  Millions
Lifemd Inc   7.62 $ 7.942  Millions$ 1  Millions
Dmk Pharmaceuticals Corporation  7.39 $ 16.216  Millions$ 2  Millions
Catalent Inc   7.08 $ 2,220.800  Millions$ 314  Millions
Horizon Therapeutics Public Limited Company  7.02 $ 465.327  Millions$ 66  Millions
Ufp Technologies Inc   6.96 $ 137.410  Millions$ 20  Millions
Enzo Biochem Inc  6.92 $ 54.488  Millions$ 8  Millions
Catalyst Pharmaceuticals Inc   6.81 $ 18.280  Millions$ 3  Millions
Align Technology inc   6.64 $ 809.353  Millions$ 122  Millions
Healthlynked Corp  6.57 $ 0.609  Millions$ 0  Millions
Genmark Diagnostics Inc   6.53 $ 91.007  Millions$ 14  Millions
Clearday Inc   6.51 $ 0.760  Millions$ 0  Millions
Sunshine Biopharma Inc   6.29 $ 0.114  Millions$ 0  Millions
Fonar Corporation  6.13 $ 10.538  Millions$ 2  Millions
Stablecoin Development Corporation  6.11 $ 3.750  Millions$ 1  Millions
Nexgel Inc   6.04 $ 0.831  Millions$ 0  Millions
Carlisle Companies Incorporated  5.86 $ 3,126.800  Millions$ 533  Millions
Avid Bioservices Inc   5.85 $ 58.143  Millions$ 10  Millions
Camp4 Therapeutics Corporation  5.81 $ 215.468  Millions$ 37  Millions

Date modified: 2023-03-22T19:14:45+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.